Skip to content

C-THAT: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

C-THAT

BE 0680.990.181
NACE 21.100, Manufacture of basic pharmaceutical products and pharmaceutical preparations
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€56,641
2024 · €78,767-€22,126
Equity
€252,115
2024 · €341,869-€89,754
Cash
€99,367
2024 · €203,618-€104,252
Balance sheet total
€379,706
2024 · €446,290-€66,584

Largest movements

2024 to 2025
Assets
  • Current investments +€200,000

    new in 2025: €200,000

  • Cash -€104,252

    down €104,252 (-51.2%), from €203,618 to €99,367

    mainly Current investments (-€200,000) and Contributions, distributions and other (-€146,396)

  • Receivables within one year -€85,354

    down €85,354 (-65.4%), from €130,540 to €45,186

    of which Trade receivables: -€73,694

  • Receivables after one year -€56,000

    no longer reported in 2025 (was €56,000)

  • Tangible fixed assets -€18,506

    down €18,506 (-44.0%), from €42,022 to €23,516

Equity and liabilities
  • Reserves -€89,754

    down €89,754 (-27.8%), from €323,269 to €233,515

  • Other debts +€15,956

    up €15,956 (+26.1%), from €61,216 to €77,172

Income statement
  • Gross operating margin -€20,854

    down €20,854 (-10.3%), from €202,982 to €182,127

  • Staff costs +€7,923

    up €7,923 (+11.0%), from €72,225 to €80,147

  • Taxes -€6,876

    down €6,876 (-28.1%), from €24,476 to €17,600

  • Write-downs +€3,453

    new in 2025: €3,453

  • Financial charges +€2,274

    up €2,274 (+114.9%), from €1,979 to €4,252

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €78,767
Gross operating margin -€20,854
Staff costs -€7,923
Depreciation +€362
Write-downs -€3,453
Other operating charges -€1,015
Other operating items +€6,215
Financial income -€60
Financial charges -€2,274
Taxes +€6,876
Result 2025 €56,641

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€242,144
Investment -€200,000
Financing -€146,396
Cash 2024 €203,618
Net result for the year +€56,641
Depreciation +€18,506
Receivables after one year +€56,000
Stocks and contracts +€3,935
Receivables within one year +€85,354
Deferred charges and accrued income -€1,463
Trade debts +€3,514
Tax, wage and social debts +€3,700
Other debts +€15,956
Current investments -€200,000
Contributions, distributions and other -€146,396
Cash 2025 €99,367
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €446,290 €379,706 -€66,584 -14.9%
Fixed assets 21/28 €47,022 €28,516 -€18,506 -39.4%
Tangible fixed assets 22/27 €42,022 €23,516 -€18,506 -44.0%
Furniture and vehicles 24 €42,022 €23,516 -€18,506 -44.0%
Financial fixed assets 28 €5,000 €5,000 = 0.0%
Current assets 29/58 €399,268 €351,190 -€48,078 -12.0%
Amounts receivable after more than one year 29 €56,000 - -€56,000
Other amounts receivable 291 €56,000 - -€56,000
Stocks and contracts in progress 3 €8,431 €4,496 -€3,935 -46.7%
Stocks 30/36 €8,431 €4,496 -€3,935 -46.7%
Amounts receivable within one year 40/41 €130,540 €45,186 -€85,354 -65.4%
Trade receivables 40 €108,157 €34,462 -€73,694 -68.1%
Other amounts receivable 41 €22,383 €10,724 -€11,660 -52.1%
Current investments 50/53 - €200,000 +€200,000
Cash at bank and in hand 54/58 €203,618 €99,367 -€104,252 -51.2%
Deferred charges and accrued income 490/1 €679 €2,142 +€1,463 +215.5%
Total equity and liabilities 10/49 €446,290 €379,706 -€66,584 -14.9%
Equity 10/15 €341,869 €252,115 -€89,754 -26.3%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €323,269 €233,515 -€89,754 -27.8%
Distributable reserves 133 €323,269 €233,515 -€89,754 -27.8%
Amounts payable 17/49 €104,422 €127,592 +€23,170 +22.2%
Amounts payable within one year 42/48 €104,422 €127,592 +€23,170 +22.2%
Trade debts 44 €2,504 €6,018 +€3,514 +140.4%
Suppliers 440/4 €2,504 €6,018 +€3,514 +140.4%
Taxes, remuneration and social security 45 €40,702 €44,402 +€3,700 +9.1%
Taxes 450/3 €30,146 €32,680 +€2,534 +8.4%
Remuneration and social security 454/9 €10,556 €11,722 +€1,167 +11.1%
Other amounts payable 47/48 €61,216 €77,172 +€15,956 +26.1%
Non-recurring operating income 76A €5,117 - -€5,117
Remuneration, social security and pensions 62 €72,225 €80,147 +€7,923 +11.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €18,869 €18,506 -€362 -1.9%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €3,453 +€3,453
Other operating charges 640/8 €2,131 €3,146 +€1,015 +47.7%
Non-recurring operating charges 66A €6,215 - -€6,215
Gross operating margin 9900 €202,982 €182,127 -€20,854 -10.3%
Operating profit (loss) 9901 €103,543 €76,875 -€26,668 -25.8%
Financial income 75/76B €1,679 €1,619 -€60 -3.6%
Recurring financial income 75 €1,679 €1,619 -€60 -3.6%
Financial charges 65/66B €1,979 €4,252 +€2,274 +114.9%
Recurring financial charges 65 €1,979 €4,252 +€2,274 +114.9%
Profit (loss) for the period before taxes 9903 €103,243 €74,242 -€29,002 -28.1%
Income taxes 67/77 €24,476 €17,600 -€6,876 -28.1%
Profit (loss) for the period 9904 €78,767 €56,641 -€22,126 -28.1%
Profit (loss) for the period to be appropriated 9905 €78,767 €56,641 -€22,126 -28.1%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.